BK Virus Infection Clinical Trials

28 clinical trials for BK Virus Infection across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• R-MVST Cells for Treatment of Viral Infections in Children and Young Adults — RECRUITING · PHASE1
• Immune Registry for BK in Kidney Transplant Recipients — RECRUITING
• Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus — RECRUITING · PHASE2
• R-MVST Cells for Treatment of Viral Infections — RECRUITING · PHASE1
• Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy — RECRUITING
• New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies — RECRUITING
• Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients — TERMINATED · PHASE1
• The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient — ACTIVE_NOT_RECRUITING · NA
• A Study to Understand How a New, Unlicensed Drug (AIC468) Works, Compared With a Placebo, Against BK Virus in Patients Who Have Had a Kidney Transplant. — NOT_YET_RECRUITING · PHASE2
• ID-ENTITY Trial- Evaluating Serial T-ID Monitoring — NOT_YET_RECRUITING
• Prediction of BK Virus Reactivation in Kidney Transplant Recipient — COMPLETED · NA
• TETRAVI Expanded Access Program — OTHER
• BK With VST for Kidney Transplant Patients — COMPLETED · PHASE1
• Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation — TERMINATED · PHASE2
• Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes — COMPLETED
• Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia — COMPLETED · PHASE2
• Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — TERMINATED · PHASE2
• Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) — TERMINATED · PHASE3
• Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — COMPLETED · PHASE2
• Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia — OTHER
• A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients — COMPLETED · PHASE2
• Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS — OTHER
• BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach — WITHDRAWN
• Ciprofloxacin for Prevention of BK Infection — COMPLETED · PHASE4
• Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient — OTHER · PHASE1
• Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) — WITHDRAWN · PHASE1
• Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients — COMPLETED · PHASE4
• BK Viremia After Renal Transplantation — OTHER · NA

Refine this search